[RASMB] RASMB Digest, Vol 67, Issue 2

Curran, Anthony P apcurran at beckman.com
Thu Sep 27 14:25:01 PDT 2018


Hi Susumu,

The filtration system which can be incorporated onto the Beckman AUCs is a higher specification than a HEPA filter. I can provide more information if needed.

Best regards,

Anthony


Anthony Curran | Senior Sales Consultant
European Analytical Ultracentrifuge Sales Specialist
a  |  Oakley Court Kingsmead Business Park  High Wycombe HP11 1JU
p  |  07802 311189  o |  01494 441181
e  |  apcurran at beckman.com
w |  www.beckman.com

-----Original Message-----
From: RASMB [mailto:rasmb-bounces at list.rasmb.org] On Behalf Of rasmb-request at list.rasmb.org
Sent: 27 September 2018 20:34
To: rasmb at list.rasmb.org
Subject: RASMB Digest, Vol 67, Issue 2

Send RASMB mailing list submissions to
rasmb at list.rasmb.org

To subscribe or unsubscribe via the World Wide Web, visit
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.rasmb.org_listinfo.cgi_rasmb-2Drasmb.org&d=DwICAg&c=9mghv0deYPYDGP-W745IEdQLV1kHpn4XJRvR6xMRXtA&r=xfWAPAxqw4DRL_JHz38F9hLvi8JYLYFRONPY9d-9oI0&m=wHTneim2qgEKQe3UXW7-_Yhvr6ZgQGnlDB0MZX8rOJY&s=2yTqpzp_-IlPx-fDUJ50f5tc2Ad9ClSJ9d8szvkWDBE&e=
or, via email, send a message with subject or body 'help' to
rasmb-request at list.rasmb.org

You can reach the person managing the list at
rasmb-owner at list.rasmb.org

When replying, please edit your Subject line so it is more specific than "Re: Contents of RASMB digest..."


Today's Topics:

   1. Re: [EXTERNAL] Serum and EH&S (Susumu UCHIYAMA)


----------------------------------------------------------------------

Message: 1
Date: Fri, 28 Sep 2018 04:33:39 +0900
From: Susumu UCHIYAMA <suchi at bio.eng.osaka-u.ac.jp>
To: rasmb at list.rasmb.org
Subject: Re: [RASMB] [EXTERNAL] Serum and EH&S
Message-ID:
<caade790-3c1f-1327-4d86-08f08201b263 at bio.eng.osaka-u.ac.jp>
Content-Type: text/plain; charset="windows-1252"; Format="flowed"

We also run AUC of proteins in serum using commercial human and murine serum (ref attached). Commercial human serum is usually tested for infectious material before selling but it might need higher level of bio-safety if you use serum from patients.
As for serum from health volunteer, it depends on the guideline of the organization.

I guess AUC has filter not HEPA but "BioSafe optional dual PALL Pharmaceutical-Grade Sterilizing Filters" which is installed for preparative UC at the vacuum exhaust.

Best,
Susumu

> *From:* RASMB [mailto:rasmb-bounces at list.rasmb.org] *On Behalf Of
> *John Sumida
> *Sent:* Wednesday, September 26, 2018 5:00 PM
> *To:* RASMB <rasmb at list.rasmb.org>
> *Subject:* [EXTERNAL] [RASMB] Serum and EH&S
>
> Dear RASMB,
>
> I apologize that this is not a scientific question, but this is,
> perhaps, a question that has come up for some on the list and I would
> be curious to hear how it was handled.
>
> We periodically field requests to spin human serum solutions, which
> invariably is a health & safety problem due to the potential for a
> cell leak and the subsequent aerosolization of a potentially hazardous
> material into the lab environment.
>
> As an academic lab, our resources and institutional motivation in
> engineering a space specific for this application are limited.? Thus,
> one suggestion was to use third party testing of samples being
> submitted for analysis. However this is costly and most users have
> abandoned their efforts to perform these measurements as a result.
>
> I would be curious to know if third party testing of potentially
> infectious materials such as human serum is commonly used within an
> EH&S setting, or if it is possible to place a HEPA filter in the
> vacuum exhaust if the instrument uses a TMP?
>
> Thank you in advance for any information you may be able to offer.
>
> Best regards
>
> John Sumida
>
> University of Washington.
>
> Individuals who have received this information in error or are not
> authorized to receive it must promptly return or dispose of the
> information and notify the sender. Those individuals are hereby
> notified that they are strictly prohibited from reviewing, forwarding,
> printing, copying, distributing or using this information in any way.
>
>
> _______________________________________________
> RASMB mailing list
> RASMB at list.rasmb.org
> https://urldefense.proofpoint.com/v2/url?u=http-3A__list.rasmb.org_lis
> tinfo.cgi_rasmb-2Drasmb.org&d=DwICAg&c=9mghv0deYPYDGP-W745IEdQLV1kHpn4
> XJRvR6xMRXtA&r=xfWAPAxqw4DRL_JHz38F9hLvi8JYLYFRONPY9d-9oI0&m=wHTneim2q
> gEKQe3UXW7-_Yhvr6ZgQGnlDB0MZX8rOJY&s=2yTqpzp_-IlPx-fDUJ50f5tc2Ad9ClSJ9
> d8szvkWDBE&e=


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://urldefense.proofpoint.com/v2/url?u=http-3A__list.rasmb.org_pipermail_rasmb-2Drasmb.org_attachments_20180928_dd3912f9_attachment.html&d=DwICAg&c=9mghv0deYPYDGP-W745IEdQLV1kHpn4XJRvR6xMRXtA&r=xfWAPAxqw4DRL_JHz38F9hLvi8JYLYFRONPY9d-9oI0&m=wHTneim2qgEKQe3UXW7-_Yhvr6ZgQGnlDB0MZX8rOJY&s=T-dQH5U4tacSs-E1Q7PyzofTrpvBdMef1pR3ZzMCTDI&e=>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: mAbs2017FDSAUC.pdf
Type: application/pdf
Size: 2239918 bytes
Desc: not available
URL: <https://urldefense.proofpoint.com/v2/url?u=http-3A__list.rasmb.org_pipermail_rasmb-2Drasmb.org_attachments_20180928_dd3912f9_attachment.pdf&d=DwICAg&c=9mghv0deYPYDGP-W745IEdQLV1kHpn4XJRvR6xMRXtA&r=xfWAPAxqw4DRL_JHz38F9hLvi8JYLYFRONPY9d-9oI0&m=wHTneim2qgEKQe3UXW7-_Yhvr6ZgQGnlDB0MZX8rOJY&s=th6mYhLMPB6gODLnhlmce4UVxrkBCfy2bXJXOSBhaLg&e=>

------------------------------

Subject: Digest Footer

_______________________________________________
RASMB mailing list
RASMB at list.rasmb.org
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.rasmb.org_listinfo.cgi_rasmb-2Drasmb.org&d=DwICAg&c=9mghv0deYPYDGP-W745IEdQLV1kHpn4XJRvR6xMRXtA&r=xfWAPAxqw4DRL_JHz38F9hLvi8JYLYFRONPY9d-9oI0&m=wHTneim2qgEKQe3UXW7-_Yhvr6ZgQGnlDB0MZX8rOJY&s=2yTqpzp_-IlPx-fDUJ50f5tc2Ad9ClSJ9d8szvkWDBE&e=


------------------------------

End of RASMB Digest, Vol 67, Issue 2
************************************
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.


More information about the RASMB mailing list